Retrospective ocular study of patients receiving oral 8-methoxypsoralen and solar irradiation for the treatment of vitiligo.
A retrospective ocular study of patients receiving oral 8-MOP and exposure to solar irradiation for the treatment of vitiligo is presented. Fifteen patients between the ages of 20 and 40 years of age were selected who had been under therapy for 5 to 23 years. No ocular abnormalities were found.
D000328:Adult; D000367:Age Factors; D005128:Eye Diseases / Q000139:chemically induced*; D005260:Female; D005500:Follow-Up Studies; D006370:Heliotherapy / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008730:Methoxsalen / Q000009:adverse effects* / Q000627:therapeutic use; D026741:Physical Therapy Modalities / Q000009:adverse effects*; D014792:Visual Acuity; D014820:Vitiligo / Q000628:therapy*
D008730:Methoxsalen